Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas

Introduction Ulcerated melanomas may have a unique biology and microenvironment. We test whether markers of immune infiltration correlate with clinical outcome in ulcerated compared to non-ulcerated primary melanoma tumors.